National Center for Advancing Translational Sciences(NCATS)
17
14M
13
4
0.24
1
- Stages of investment
- Areas of investment
Summary
Besides, a startup needs to be aged 4-5 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Hesperos, Intabio, UAMS Translational Research Institute. Among the most popular fund investment industries, there are Association, Biopharma.
Deals in the range of 5 - 10 millions dollars are the general things for fund. The fund is generally included in 2-6 deals every year. The high activity for fund was in 2018.
The standard case for the fund is to invest in rounds with 1 partaker. Despite the National Center for Advancing Translational Sciences(NCATS), startups are often financed by Genoa Ventures. In the next rounds fund is usually obtained by Northpond Ventures, National Institutes of Health, Genoa Ventures.
Investments analytics
Analytics
- Total investments
- 17
- Lead investments
- 4
- Exits
- 1
- Follow on index
- 0.24
- Investments by industry
- Biotechnology (13)
- Pharmaceutical (6)
- Health Care (5)
- Life Science (5)
- Education (3) Show 12 more
- Investments by region
-
- United States (17)
- Peak activity year
- 2022
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 22
- Group Appearance index
- 0.06
- Avg. company exit year
- 6
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Habito | 12 Aug 2020 | Financial Services, FinTech, Finance | Late Stage Venture | 45M | England, London, United Kingdom |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.